PCSK9 vaccine
US9987341B2 · kind B2 · utility
0Cited by
6References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 2016 |
| Grant date | Jun 5, 2018 |
| Priority date | — |
| Expiry date | Sep 15, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N9/6424
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.